Degradation of intrinsically disordered proteins (IDPs) by the 20S proteasome, unlike ubiquitin-dependent 26S proteasomal degradation, does not require proteasomal targeting by polyubiquitin. However, how these proteins are recognized by the proteasome was unknown. We report here on a mechanism of 20S proteasome 
Introduction
Protein degradation plays key roles in diverse cellular processes and cell fate determination including proliferation, differentiation, death, antigen processing, DNA repair, inflammation and stress response as reviewed 1, 2 . A major regulatory route of protein degradation is controlled by the proteasome particles. Failure of the proteasome system and the resulting changes in protein homeostasis has been linked with human diseases and pathologies [2] [3] [4] .
The 26S proteasome is an abundant cellular complex catalyzing protein degradation. It contains a 20S barrel-shaped proteolytic core particle, capped at one or both ends by the 19S regulatory complexes. The 20S proteasome is composed of four stacked rings in a barrel shape, two PSMA and two PSMB rings. Proteolytic activity resides in the chamber formed by the inner PSMB rings. The outer PSMA rings are identical and each has seven distinct subunits. The N-termini of the PSMA subunits form a gated orifice controlling substrate entry into the proteasome ( Figure 1a ). The 20S proteasome regulatory particles, including 19S, PA28, PA200, each interact with the PSMA ring, modulating its activity by opening the narrow entrance into the orifice and improving accessibility of substrates into the catalytic chamber [5] [6] [7] [8] [9] [10] Proteins destined for degradation are first identified as "legitimate" substrates by the proteasomes prior to undergoing degradation 11, 12 . To this end, protein substrates target the proteasome via protein-protein interaction. The major targeting mechanism is the ubiquitin-dependent pathway. Polyubiquitin chains are covalently attached to the substrates, marking them for proteasome recognition and subsequent degradation. The polyubiquitin chain binds the 19S regulatory particle of the 26S
proteasome directly or through transiently-associated 19S proteins [13] [14] [15] . To date, three of the subunits of the 19S particle, namely Rpn1, Rpn10 and Rpn13 were identified as ubiquitin receptors 16 . In the second pathway, no major prior protein modifications are required for targeting to the proteasomes. A well-known example of this pathway is ODC and antizyme. Binding of ODC by antizyme leads to proteasomal association and degradation 17, 18 . However, a growing number of proteins undergo proteasomal degradation by other mechanisms [19] [20] [21] [22] [23] [24] [25] . Since interaction of the substrate with the proteasome is a requisite step in proteasomal degradation, the question of how these substrates are targeted to the proteasomes remained open. A considerable number of proteins undergo ubiquitin-independent degradation and by large are either completely or partially intrinsically disordered 26 .
Over the last two decades many proteins have been identified as containing extensive disordered regions, and some proteins are even completely disordered under physiological conditions 27, 28 . These proteins were termed either as natively unfolded 29 , intrinsically disordered proteins (IDPs) 27,28 and 4D proteins 30 . IDPs are involved in many key cellular processes, including transcription regulation and signal transduction 31 .
IDPs undergo 26S proteasomal degradation by the ubiquitination pathway.
However, certain IDPs were shown to also undergo ubiquitin-independent proteasomal degradation in vitro using purified 20S proteasomes. The fact that these proteins are intrinsically unfolded negates the requirement of the 19S regulatory particle in unfolding the substrates. In fact, IDPs degradation by the 20S proteasome in vitro can be implemented in operational definition of this group of proteins 30 . The notion is that this particle is gated and found in a latent state 14 . However, allosteric mechanisms were suggested in opening the gate 32 and whether this is the case with the 20S particle is an open question.
Certain observations hint toward the possibility that the 20S proteasome is functional in the cells 33 , especially under stringent conditions [34] [35] [36] [37] [38] . Furthermore, in certain cases the physiological importance of the in vivo 20S activity was addressed [39] [40] [41] [42] [43] . Since in this process ubiquitin is dispensable and the 19S particle-associated substrate receptors are absent, the mechanism of 20S particle targeting remained an open question.
We analyzed protein-protein interaction datasets and found that PSMA3, a 20S particle subunit, is an interaction hub for a subset of IDPs. We adopted the BiFC technique to validate our finding and mapped the interaction domain to the PSMA3 C-terminus. We further show that the PSMA3 C-terminal region works in heterologous contexts and in isolation to trap substrate candidates. Data obtained from in vitro and in cell experiments revealed that the trapper functions in facilitating IDPs ubiquitin-independent degradation. We propose a model whereby the 20S catalytic particle has a substrate receptor to trap certain IDPs for degradation.
Results

PSMA3 as an IDP-binding hub of the 20S proteasome
We have previously reported that certain intrinsically disordered proteins undergo proteasomal degradation by the 20S catalytic subunit 39, 41, 42, [44] [45] [46] . Given the fact that this process is ubiquitin-independent, the question of how the IDP substrates are recognized by the 20S proteasomal complex remained an open question. We assumed that an inherent component of the 20S complex might play a role of IDP trapper. Our assumption was that the putative IDP trapper is likely to be located in the PSMA ring as this ring forms the entry into the catalytic chamber ( Figure 1a) . To challenge this model we took advantage of the interactome data sets with the rationale that the PSMAs interacting proteins are potential 20S substrates. We analyzed the IMEx data resource which searches different databases of large-scale protein-protein interaction screens 47 . The analysis revealed that PSMA3 and PSMA1 are the preferred protein-binding constituents (Figure 1b and supplementary table 1) . Next, using the IUPred algorithm 48 we evaluated the percent disorder of the PSMAs interacting proteins. We found that the PSMA3-interacting proteins are uniquely highly enriched for IDPs (Figure 1c) . We also compared PSMA3-interacting proteins found in the IMEx data resource to PSMA3-interacting proteins found in the HI.II.14 dataset from the human interactome project 49 . The interacting proteins found in the HI.II.14 dataset are also enriched with IDPs ( Figure 1d ). These analyses support the possibility that PSMA3 might play a role of IDP substrate trapper in the process of ubiquitin-independent 20S proteasomal degradation.
Chimeric PSMA3 produce BiFC with p21
We adopted the bimolecular fluorescence complementation (BiFC) assay 50, 51 as a strategy to examine PSMA3 interaction with IDPs in cells. In this assay, the reporter fluorescent protein (FP) is split into two fragments; the C-terminus FPC and the N-terminus FPN, which upon their interaction emit a fluorescent signal. PSMA subunits were fused to FPC and the ubiquitin-independent proteasomal substrates were fused to FPN (Figure 2a) . When PSMA and a potential substrate protein interact, the fluorescent fragments are brought into proximity, interact and fluorescence is restored ( Figure 2b ). The interacting chimeric subunits may emit a signal as free subunits or in the context of the proteasomes upon incorporation of the chimeric PSMA subunits.
p21 is an IDP 52,53 which undergoes both ubiquitin-dependent and independent proteasomal degradation 54, 55 . In order to examine p21 interaction with PSMA3 we generated a chimeric 6xmyc p21 FPN. The myc tag minimizes p21 proteasomal degradation 55 , to detect proteasomal recognition without compromising p21 level.
BiFC signal of HeLa cells transiently co-transfected with PSMA3, 6, 5-FPC and p21-FPN was monitored by microscopy and FACS quantification. Chimeric PSMA 6 and 5-FPC were used as controls to evaluate the noise of the system. p21 gave the strongest signal when co-transfected with PSMA3 ( figure 2c-d) . We examined expression levels of the constructs in the cells used for FACS analysis to verify that the BiFC signal differences didn't stem from different expression levels. PSMA3 and 6 were expressed to the same level thus excluding the possibility that BiFC efficiency differed because of expression (figure 2e). These data suggest that PSMA3
preferentially interacts with the intrinsically disordered protein p21.
The PSMA3-FPC chimera is incorporated into proteasomes
In order to determine whether the PSMA3-FPC chimera is incorporated into the proteasomes we used native gel analysis. The analysis revealed that the PSMA3- 
The PSMA3 C-terminus is sufficient to interact with p21
The PSMA subunits mainly differ at their C-termini 56 and PSMA3 Cterminus (Ct 187-255) is exposed enough in the 20S and 26S proteasomes to interact with IDP substrates (Figure 4a and supplement figure 1). Thus, we speculated that the PSMA3-Ct is the most likely p21-interacting region. To examine this possibility we constructed truncation mutants in the C-terminus of the chimeric PSMA3 (supplement figure 2a). Based on the secondary structure of PSMA3, the truncation was done at the flexible regions. Truncation longer than the last C-terminal 11 amino acid residues (Ct-Δ11) reduced the expression level of the subunit (supplement figure 2b).
However, the Ct-Δ26 and Ct-Δ69 mutants were expressed to the same level yet the BiFC signal was markedly reduced in the Ct-Δ69 mutant (supplement figure 2c),
suggesting that the PSMA3-Ct187-229 region recognizes p21. The crystal structure of PSMA3 suggests that the Ct187-229 region is adequately accessible to the surrounding proteins ( Figure 4b ).
We next asked whether this region is sufficient to interact with p21 by conducting fragment swapping experiments. We chose PSMA5 to be swapped with the PSMA3-Ct as the BiFC signal with PSMA5 was weak with minimal background We also generated reciprocal PSMA3ΔCt-5Ct constructs (supplement figure 3a-b). However, these constructs were expressed at much lower levels than the control, preventing reliable analysis, and therefore were not subjected to further studies (supplement figure 3c).
The PSMA5 ΔCt -3Ct both long and short versions were efficiently expressed (supplement figure 3d). FACS quantification showed that both PSMA5 ΔCt-3Ct long and short yielded better BiFC with p21 than PSMA5 wt ( Figure 4g ).
We next examined if c-Fos, another IDP 57 , which also can undergo ubiquitinindependent degradation 39,40 interacts with PSMA3-Ct. PSMA5 ΔCt -3Ct long and short gave a higher BiFC with c-Fos than PSMA5 wt ( Figure 4h ). Notably, the longer PSMA5 ΔCt-3Ct construct was significantly more efficient in emitting fluorogenic signals with p21 and c-Fos (Figure 4g -h).
To further validate the role of PSMA3-Ct region in interacting with IDPs, we conducted co-immunoprecipitation experiments. For this set of experiments we used a 6xmyc-tagged p21 construct lacking the FPN moiety and found it to be coimmunoprecipitated with the chimeric PSMA5 ΔCt-3Ct long and short swapped constructs but not with the naïve PSMA5 ( Figure 4i ). These data suggest that the PSMA3-Ct is sufficient in interacting with p21 also in the PSMA5 context.
Recombinant PSMA3 trapper interacts with a subset of IDPs
To demonstrate that PSMA3-Ct plays a role of IDP trapper we examined its capacity to interact with IDPs in isolation using a recombinant GST fusion protein containing the putative PSMA3-Ct187-255 IDPs trapper. We used two controls, the GST-PSMA5-Ct chimeric protein, where the PSMA5-Ct188-241, which is structurally analogous to the trapper region of PSMA3 were fused to GST, and as a second control we used the recombinant GST ( Figure 5a ). HEK293 cell extract overexpressing 6xmyc p21 was incubated with purified GST-fusion proteins bound to glutathione-agarose beads and eluted fractions were analyzed by immunoblotting.
Remarkably, the 6xmyc p21 was efficiently pulled down only with the GST-PSMA3-Ct putative trapper ( Figure 5b ).
Next, we examined the recombinant trapper ability for pulling down specific endogenous IDPs, such as c-Fos and p53, which were shown to undergo ubiquitinindependent degradation 41, 42, 58 . Remarkably, the PSMA3 trapper fragment To examine the involvement of the PSMA3 trapper in p53 degradation in the cells we employed our published protocol 59 . We have previously shown that NQO1 protects p53 from ubiquitin-independent proteasomal degradation and that dicoumarol, an 
The PSMA3 trapper regulates c-Fos degradation
We next examined c-Fos degradation using an experimental setting where it undergoes ubiquitin-independent degradation in cells 39, 40 
PSMA3 trapper facilitates 20S proteasomal degradation of many IDPs in vitro
We 
Discussion
PSMA3 is an IDP-interacting hub of the proteasome
A key regulatory process in proteostasis is ubiquitin-dependent proteasomal degradation. In this process substrates are ubiquitinated and targeted to the 26S proteasome for degradation. Ubiquitinated substrates interact directly with the 19S subunits Rpn1, Rpn10 and Rpn13, as a mechanism of substrate recruitment 16 . In this study, we examined the possibility of substrate recognition by an alternative and ubiquitin-independent mechanism. This study was motivated by the findings that certain proteins, in particular IDPs, are proteasomally degraded in the absence of ubiquitination 26 . Based on the analysis of interactome data sets we identified the 20S proteasome subunit PSMA3 as an IDP interacting hub and assumed that PSMA3 plays a role of an IDP receptor. We took a number of in vivo and cell free experimental approaches to validate this finding and to demonstrate that PSMA3 interacts with and facilitates IDPs degradation. These findings led to the identification of a novel substrate trapper embedded in the C-terminus of PSMA3, a 20S proteasome subunit. This conclusion is based on the following observations. Using a BiFC system we demonstrated that the PSMA3 subunit and specifically its Cterminus interacts with the IDPs p21 and c-Fos. We further showed that the isolated PSMA3 C-terminus is sufficient to interact with p21, c-Fos and p53 using a coimmunoprecipitation strategy. Based on these attributes we termed the element a substrate trapper. Although we have directly investigated only the p21, p53 and c-Fos substrates, we assume that a larger number of IDPs are likely to be trapped. This view is based on our finding that excess of recombinant trapper, that was shown to be active in binding the tested proteins, markedly reduces the degradation of pools of cellular IDPs by the 20S proteasome.
The proteasome species that degrade IDPs
A few species of proteasomes are found in cells and they differ by the type of regulatory particle associated with the catalytic 20S particle. Cells contain relatively large amounts of the 20S particles but whether they are physiologically functional is debatable. The accepted assumption is that this particle is in a latent state and tightly gated to minimize unscheduled protein degradation 14 . However, given the fact that the mechanism of the gate opening neither in the context of the 26S proteasome nor the free 20S form is settled, we need to rely on empirical evidence for the possible in vivo activity of the 20S particle. For example, proteins damaged by oxidation were
shown to undergo ubiquitin-independent degradation by the 20S proteasome 33 . Both oxidative damage and prolonged cell starvation stress results in 26S proteasome disassembly and 20S accumulation 34-36 . p53 and c-Fos are both stress response IDPs and both are 20S proteasome substrates [39] [40] [41] [42] . Furthermore, two independent groups have found that reducing the expression of the 19S regulatory particle subunits improves viability of cells treated with 20S proteasome inhibitors 37, 38 , attributing an active role to the 20S particle in cell fate determination. Finally, in the nervous system, membrane-associated 20S proteasomes modulate the calcium signaling induced by neuronal activity 43 . All these findings support the possibility of at least a fraction of 20S particles playing physiological roles and that the identified PSMA3
IDP trapper is likely to regulate these processes.
Recently our lab reported the existence of another form of 26S proteasome.
The 26S proteasome is also stable when it binds the small molecule NADH without the need for ATP 64 . We have evidence that the 26S NADH proteasome can efficiently degrade IDPs, unlike 26S ATP-stabilized proteasome. In addition, the identified PSMA3 trapper region is exposed in the 26S proteasome (supplement figure 1). Thus, one can think of the possibility that the 26S NADH proteasome can trap IDPs through PSMA3.
The PSMA3 substrate receptor
The PSMA subunits are highly similar but are unique at their C-terminus 56 .
The PSMA3 C-terminal region bears a helix-strand-helix structural motif (Fig 4) .
Deletion mutants revealed that the removal of the C-terminus α helix region, the last 26 aa residues, sharply reduces protein accumulation of this construct, therefore the trapper region determines PSMA3 protein level as well. The identified trapper region is rather charged, but since other PSMAs are also highly charged at their C-termini but lack IDP trapping activity, we assume that the charged residues might be required but are not sufficient to function as substrate trapper. All the PSMA subunits Ctermini contain the helix-strand-helix motif but with a different helix-to-helix positioning, which is likely to contribute to the selection of the client proteins.
We demonstrated both in-vitro and in cells that the PSMA3 substrate trapper region is an autonomous module and in isolation is active in substrate binding. We took advantage of its autonomous behavior to sequester the client proteins in binding the 20S particle. The obtained data are consistent with the proposed model ( Figure   7e ) that trapper accessibility is a prerequisite step in substrate degradation.
Mechanistically, the receptor-substrate interaction would position the substrate close to the 20S catalytic orifice. In addition, we would like to speculate that this interaction may facilitate orifice opening. In the 20S proteasome the orifice is occluded by the N termini of the PSMA ring subunits, thus creating a gate limiting access into the proteolytic chamber 8, 65, 66 Furthermore, the gate in the 26S proteasome is also largely found in a closed 
Regulation of the trapper-mediated substrate selection
A key question is how the IDP trapper/degradation is regulated to permit substrate discrimination. It is well demonstrated that IDPs undergo rather extensive post-translational modifications [74] [75] [76] . These modifications, largely S/T phosphorylation, might very well increase or decrease trapper binding. Also, previously we reported on nanny proteins that interact with IDPs to escape their proteasomal degradation 77 . Nanny proteins therefore might function to help the substrate in escaping the trapper. According to these models, trapper interaction takes place by default unless the system instructs otherwise. This model is different from the ubiquitination process where the substrate is stable unless marked by ubiquitin.
Materials and methods: Tissue culture
The cell lines used were: HEK293, U2OS, HCT116 and HeLa. Cells were grown in DMEM supplemented with 8% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin and cultured at 37°C in a humidified incubator with 5.6% CO2.
Plasmids, transfection and infection
Plasmids used: PCDNA3 CFP and PCDNA3 CFP PSMA3 187-255aa. PSMA 
Immunoblot analysis
Cells were lysed with NP40 buffer (20mM Tris-HCl pH7.5, 320mM sucrose, 5mM Signals were detected using the EZ-ECL kit (Biological Industries).
Glycerol gradient
HEK293 cell were lysed in 0.5ml NP40 buffer and loaded on an 11ml linear 10%-40% glycerol gradient and centrifuged 16 hours at 28,400 rpm, using rotor SW 41TI.
0.5ml fractions were collected and analyzed by western blot and fluorometer.
Co-immunoprecipitation
Samples were incubated with primary antibody 16h. Samples were washed 6 times with NP40 buffer. Bound and associated proteins were eluted with Laemmli sample buffer or HA peptide (Sigma) according to standard protocol.
Nondenaturing PAGE
Samples were prepared and run as described 42 .
BiFC analysis
Cells were co-transfected with PSMA subunit-FPC, potential substrate-FPN and to each fraction to a final volume of 20%, following elution, in order to preserve proteasome activity. Eluted fractions were dialyzed against a buffer containing 50mM
Tris-HCl (pH 7.5), 5mM MgCl 2 and 20% glycerol. Purest fractions containing proteasomes were pooled and concentrated using a Millipore 100kDa-cut off concentrator. Protein concentration was estimated by Bradford Assay, purification purity was visualized on an SDS-PAGE gel by a Coomassie stain (InstantBlue Expedeon) and Proteasome activity was determined by the ability to hydrolyze the fluorogenic peptide suc-LLVY-AMC. Proteasomes were aliquoted, flash-frozen in liquid nitrogen and stored at -80°C.
GST pull down
Recombinant GST proteins bound to glutathione agarose were incubated in a rotator with treated or naïve cell lysate 16h at 4°C. Beads were washed with NP40 buffer 6X300µl and recombinant GST and associated proteins were eluted from glutathione agarose beads with 70µl of 10mM glutathione in 50mM Tris-HCl pH 9.5.
In-vitro degradation assay
Degradation of recombinant baculovirus expressed and purified p53 (kindly provided 
Purified p53
Infection and purification of recombinant baculovirus-expressed human p53 from insect cells was done as described 83 .
Data analysis
Data analysis was preformed with a web-tool for plotting box plots Step I, the PSMA subunit fused to FPC and the substrate candidate fused to FPN are co-expressed; step II, the substrate interacts with the cognate PSMA subunit to increase substrate-proteasome accessibility; step III, the fluorescent protein refolds and fluorescence is restored. The chimeric PSMA subunit may or may not be incorporated into the 20S proteasome (c-e) HeLa cells were co-transfected with 6xmyc p21 FPN, chimeric PSMA3,5,6 subunits and H2B RFP. 
